169 related articles for article (PubMed ID: 21875615)
1. Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats.
Long JM; Lee GD; Kelley-Bell B; Spangler EL; Perez EJ; Longo DL; de Cabo R; Zou S; Rapp PR
Pharmacol Biochem Behav; 2011 Nov; 100(1):205-11. PubMed ID: 21875615
[TBL] [Abstract][Full Text] [Related]
2. Transient improvement in cognitive function and synaptic plasticity in rats following cancer chemotherapy.
Lee GD; Longo DL; Wang Y; Rifkind JM; Abdul-Raman L; Mamczarz JA; Duffy KB; Spangler EL; Taub DD; Mattson MP; Ingram DK
Clin Cancer Res; 2006 Jan; 12(1):198-205. PubMed ID: 16397043
[TBL] [Abstract][Full Text] [Related]
3. Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity.
Fardell JE; Vardy J; Shah JD; Johnston IN
Psychopharmacology (Berl); 2012 Mar; 220(1):183-93. PubMed ID: 21894483
[TBL] [Abstract][Full Text] [Related]
4. Preserved learning and memory in mice following chemotherapy: 5-Fluorouracil and doxorubicin single agent treatment, doxorubicin-cyclophosphamide combination treatment.
Fremouw T; Fessler CL; Ferguson RJ; Burguete Y
Behav Brain Res; 2012 Jan; 226(1):154-62. PubMed ID: 21930159
[TBL] [Abstract][Full Text] [Related]
5. Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice.
Walker EA; Foley JJ; Clark-Vetri R; Raffa RB
Psychopharmacology (Berl); 2011 Oct; 217(4):539-48. PubMed ID: 21537942
[TBL] [Abstract][Full Text] [Related]
6. Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy.
Christie LA; Acharya MM; Parihar VK; Nguyen A; Martirosian V; Limoli CL
Clin Cancer Res; 2012 Apr; 18(7):1954-65. PubMed ID: 22338017
[TBL] [Abstract][Full Text] [Related]
7. Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats.
Winocur G; Wojtowicz JM; Huang J; Tannock IF
Psychopharmacology (Berl); 2014 Jun; 231(11):2311-20. PubMed ID: 24343419
[TBL] [Abstract][Full Text] [Related]
8. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients.
Schagen SB; Muller MJ; Boogerd W; Rosenbrand RM; van Rhijn D; Rodenhuis S; van Dam FS
Ann Oncol; 2002 Sep; 13(9):1387-97. PubMed ID: 12196364
[TBL] [Abstract][Full Text] [Related]
9. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.
Schagen SB; van Dam FS; Muller MJ; Boogerd W; Lindeboom J; Bruning PF
Cancer; 1999 Feb; 85(3):640-50. PubMed ID: 10091737
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term infusion of sedatives on the cognitive function and expression level of RAGE in hippocampus of rats.
Wang J; Niu M; Bai S
J Anesth; 2016 Aug; 30(4):691-5. PubMed ID: 27294272
[TBL] [Abstract][Full Text] [Related]
11. Cancer chemotherapy impairs contextual but not cue-specific fear memory.
Macleod JE; DeLeo JA; Hickey WF; Ahles TA; Saykin AJ; Bucci DJ
Behav Brain Res; 2007 Jul; 181(1):168-72. PubMed ID: 17509697
[TBL] [Abstract][Full Text] [Related]
12. Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model.
Winocur G; Binns MA; Tannock I
Neuropharmacology; 2011 Dec; 61(8):1222-8. PubMed ID: 21803055
[TBL] [Abstract][Full Text] [Related]
13. Post-treatment with cotinine improved memory and decreased depressive-like behavior after chemotherapy in rats.
Iarkov A; Appunn D; Echeverria V
Cancer Chemother Pharmacol; 2016 Nov; 78(5):1033-1039. PubMed ID: 27709283
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide impairs hippocampus-dependent learning and memory in adult mice: Possible involvement of hippocampal neurogenesis in chemotherapy-induced memory deficits.
Yang M; Kim JS; Song MS; Kim SH; Kang SS; Bae CS; Kim JC; Wang H; Shin T; Moon C
Neurobiol Learn Mem; 2010 May; 93(4):487-94. PubMed ID: 20109567
[TBL] [Abstract][Full Text] [Related]
16. A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).
von Minckwitz G; Conrad B; Reimer T; Decker T; Eidtmann H; Eiermann W; Hackmann J; Möbus V; Marmé F; Potenberg J; Stickeler E; Simon E; Thomssen C; Huober J; Denkert C; Alfer J; Jackisch C; Nekljudova V; Burchardi N; Loibl S;
Cancer; 2015 Oct; 121(20):3639-48. PubMed ID: 26111104
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients.
Cruzado JA; López-Santiago S; Martínez-Marín V; José-Moreno G; Custodio AB; Feliu J
Support Care Cancer; 2014 Jul; 22(7):1815-23. PubMed ID: 24535240
[TBL] [Abstract][Full Text] [Related]
18. NMDA receptor channel antagonism by dizocilpine (MK-801) impairs performance of rats in aversively motivated complex maze tasks.
Spangler EL; Bresnahan EL; Garofalo P; Muth NJ; Heller B; Ingram DK
Pharmacol Biochem Behav; 1991 Dec; 40(4):949-58. PubMed ID: 1667826
[TBL] [Abstract][Full Text] [Related]
19. The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial.
Mosconi S; Cascinu S; Zaniboni A; Catalano V; Giordani P; Beretta GD; Martignoni G; Pancera G; Baldelli AM; Poletti P; Curti C; Labianca R
Tumori; 2000; 86(6):465-9. PubMed ID: 11218187
[TBL] [Abstract][Full Text] [Related]
20. Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis.
Sanoff HK; Carpenter WR; Freburger J; Li L; Chen K; Zullig LL; Goldberg RM; Schymura MJ; Schrag D
Cancer; 2012 Sep; 118(17):4309-20. PubMed ID: 22294436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
